FIELD: medicine, pharmaceutics.
SUBSTANCE: group of invention refers to ophthalmic compositions containing protease inhibition peptide substrates. The ophthalmic compositions contains a peptide substrate in a solution in the amount of approximately 0.01 wt/vol. % to 10 wt/vol. %, and said substrate is specified in a group consisting of gelatin, ovomacroglobulin, collagen and casein in an ophthalmically acceptable carrier. The composition additionally contains galactomannan and borate. The invention also describes a method for using the composition for treating dry eye.
EFFECT: group of invention provides higher viability and lower water loss of corneal epitheliocytes.
12 cl, 12 dwg, 11 ex
| Title | Year | Author | Number |
|---|---|---|---|
| OPHTHALMIC COMPOSITIONS WITH IMPROVED DESSICATION PROTECTION AND RETENTION | 2013 |
|
RU2659207C2 |
| OPHTHALMIC COMPOSITIONS WITH POLY(ETHYLENE OXIDE)-POLY(BUTYLENE OXIDE) BLOCK COPOLYMERS | 2010 |
|
RU2548789C2 |
| METHOD OF PRODUCING TRIPEPTIDE CONTAINING OLEANOLIC ACID AND ITS THERAPEUTIC APPLICATIONS | 2018 |
|
RU2733372C1 |
| SUSPENSIONS OF NANOPARTICLES, CONTAINING CARBOXYVINYL POLYMER | 2010 |
|
RU2571078C2 |
| PHARMACEUTICAL COMPOSITION AND METHODS OF TREATING DRY-EYE SYNDROME | 2008 |
|
RU2445098C2 |
| PEPTIDE FOR THE PREVENTION OF SKIN DAMAGE CAUSED BY ATMOSPHERIC POLLUTION AND FOR ANTI-AGING THERAPY, AS WELL AS ITS USE | 2019 |
|
RU2773534C1 |
| OPHTHALMIC COMPOSITIONS | 2020 |
|
RU2798842C1 |
| BROMELAIN EXTRACT WITH PROTEOLYTIC ACTIVITY TO TREAT CONNECTIVE TISSUE DISEASES | 2012 |
|
RU2625726C2 |
| COMPOSITIONS AND METHODS FOR NON-SURGICAL TREATMENT OF PTOSIS | 2012 |
|
RU2582392C2 |
| BIFUNCTIONAL PEPTIDE | 2013 |
|
RU2639573C2 |
